Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson’s Disease
Cambridge, Mass. and Burnaby, British Columbia , June 06, 2022 (GLOBE NEWSWIRE) — Biogen and…
Housecall Pro Integrates with AI Mode in Google Search to Turn Home Service Searches into Booked Jobs
Pitches and Keynote Speakers Are Confirmed for Blue Magic Netherlands on November 17
The 34th Hong Kong International Optical Fair opens today
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Approved in Singapore, Filling Gap in Vitiligo Treatment
Payment Cards Group (A3A PayTech) Joins HKMA’s Agentic Finance Expert Group